Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Benoit You"'
Autor:
Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, Florence Dalenc, Marie-Paule Sablin, Mario Campone, Hervé Bonnefoi, Claudia Lefeuvre-Plesse, William Jacot, Florence Coussy, Jean-Marc Ferrero, George Emile, Marie-Ange Mouret-Reynier, Jean-Christophe Thery, Nicolas Isambert, Alice Mege, Philippe Barthelemy, Benoit You, Nawale Hajjaji, Ludovic Lacroix, Etienne Rouleau, Alicia Tran-Dien, Sandrine Boyault, Valery Attignon, Pierre Gestraud, Nicolas Servant, Christophe Le Tourneau, Linda Larbi Cherif, Isabelle Soubeyran, Filippo Montemurro, Alain Morel, Amelie Lusque, Marta Jimenez, Alexandra Jacquet, Anthony Gonçalves, Thomas Bachelot, Ivan Bieche
Publikováno v:
Nature
Nature, 2022, 610 (7931), pp.343-348. ⟨10.1038/s41586-022-05068-3⟩
Nature, 2022, 610 (7931), pp.343-348. ⟨10.1038/s41586-022-05068-3⟩
Cancer progression is driven in part by genomic alterations
Autor:
Fabienne Allias, Benoit You, Touria Hajri, Mojgan Devouassoux-Shisheboran, François Mallet, François Golfier, Jérôme Massardier, Sophie Patrier, Jonathan Lopez, Pierre-Adrien Bolze
Publikováno v:
Gynecologic Oncology
Gynecologic Oncology, 2020, 158, pp.785-793. ⟨10.1016/j.ygyno.2020.05.042⟩
Gynecologic Oncology, Elsevier, 2020, 158, pp.785-793. ⟨10.1016/j.ygyno.2020.05.042⟩
Gynecologic Oncology, 2020, 158, pp.785-793. ⟨10.1016/j.ygyno.2020.05.042⟩
Gynecologic Oncology, Elsevier, 2020, 158, pp.785-793. ⟨10.1016/j.ygyno.2020.05.042⟩
International audience; Objective: Using a transcriptional approach on tissue samples, we sought to identify predictive biomarkers of post molar malignant transformation, and of choriocarcinoma chemosensitivity to mono- (methotrexate or actinomycin D
Autor:
Mathilde Cancel, Oana Pop, Alain Lortholary, C.B. Levaché, Daniel Pissaloux, Magali Provansal, Elsa Kalbacher, Rémy Largillier, Amélie Anota, Audrey Lardy-Cleaud, Jérôme Meunier, Christophe Louvet, Anne-Claire Hardy-Bessard, Aurélie Houlier, Marie-Ange Mouret-Reynier, Fabien Brocard, Benoit You, Anne Floquet, Cyril Abdeddaim, Aude-Marie Savoye, Isabelle Ray-Coquard, Alain Zannetti, Laurence Venat-Bouvet, Isabelle Treilleux, Olivier Tredan, Jean-Sebastien Frenel
Publikováno v:
Gynecologic Oncology
Gynecologic Oncology, 2022, 164 (1), pp.18-26. ⟨10.1016/j.ygyno.2021.09.024⟩
Gynecologic Oncology, 2022, 164 (1), pp.18-26. ⟨10.1016/j.ygyno.2021.09.024⟩
Objective To evaluate the efficacy and safety of regorafenib versus tamoxifen in platinum-sensitive ovarian cancer biological recurrence, defined by CA-125 increase without radiological (RECIST criteria) or symptomatic evidence of progression. Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442e0efad461a61c2ee12df093873312
https://hal.archives-ouvertes.fr/hal-03868128
https://hal.archives-ouvertes.fr/hal-03868128
Autor:
Frédéric Marchal, Catherine Arvieux, B. Paquette, Naoual Bakrin, Diane Goéré, Marc Pocard, Peggy Dartigues, Julio Abba, Charles Honoré, Denis Pezet, Olivia Sgarbura, R. Lo Dico, P. Rousset, Jérémie H. Lefevre, Maximiliano Gelli, Frédéric Guyon, Abdelkader Taibi, Clarisse Eveno, Sylvaine Durand-Fontanier, Benoit You, J. Fontaine, Olivier Bouché, Jean-Baptiste Delhorme, Olivier Glehen, Karine Abboud, C. Nadeau, Vahan Kepenekian, L. Gladieff, Jean-Jacques Tuech, Laurent Villeneuve
Publikováno v:
Journal of Visceral Surgery
Journal of Visceral Surgery, Elsevier, 2020, 157, pp.S25-S31. ⟨10.1016/j.jviscsurg.2020.04.013⟩
Journal of Visceral Surgery, Elsevier, 2020, 157, pp.S25-S31. ⟨10.1016/j.jviscsurg.2020.04.013⟩
The Covid-19 pandemic is profoundly changing the organization of healthcare access. This is particularly so for peritoneal neoplastic diseases, for which curative treatment mobilizes substantial personnel, operating room and intensive care resources.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e8dce6b533c0d60a23972e0b33518d
https://hal.archives-ouvertes.fr/hal-03491023
https://hal.archives-ouvertes.fr/hal-03491023
Autor:
Jérôme Meunier, Florence Joly, Joël Lachuer, E. Malaurie, Marie-Christine Kaminsky, Dominique Berton-Rigaud, Jérôme Alexandre, Gaëtan de Rauglaudre, Coraline Dubot, Michel Tod, Patrick Robelin, Olivier Colomban, Alexandra Leary, Gwenael Ferron, Isabelle Ray-Coquard, Alain Lortholary, Annick Chevalier-Place, Salima Hamizi, Benoit You, N. Raban, Pierre Combe
Publikováno v:
Gynecologic Oncology
Gynecologic Oncology, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
Gynecologic Oncology, Elsevier, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
Gynecologic Oncology, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
Gynecologic Oncology, Elsevier, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
International audience; Objective: MicroRNAs (miRNAs) are promising biomarkers in ovarian cancer. Their kinetics during treatment might be useful for monitoring disease burden, and guiding treatments in patients treated with peri-operative chemothera
Autor:
Benoit You, Orit Kaidar-Person, Etienne Brain, Ignacio Zapardiel, Nienke A. de Glas, Susana Banerjee, Maxime Frelaut, Manuel Rodrigues, Claire Falandry, Maria Kfoury
Publikováno v:
Cancers
Contemporary Southeast Asia
Contemporary Southeast Asia, Taylor & Francis, 2019, 11 (12), ⟨10.3390/cancers11121955⟩
Cancers, 2019, 11 (12), ⟨10.3390/cancers11121955⟩
Volume 11
Issue 12
Contemporary Southeast Asia
Contemporary Southeast Asia, Taylor & Francis, 2019, 11 (12), ⟨10.3390/cancers11121955⟩
Cancers, 2019, 11 (12), ⟨10.3390/cancers11121955⟩
Volume 11
Issue 12
Although a quarter of cervical cancers occur after the age of 65 years, there is no treatment consensus for these patients. The aim of this work was to survey how physicians treat patients with advanced cervical cancer, focusing on treatment adjustme
Autor:
Jonathan Lopez, Mévidette El-Madani, Michel Tod, Julien Péron, Pauline Corbaux, Gilles Freyer, Benoit You, Denis Maillet
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2019, 120, pp.40-46. ⟨10.1016/j.ejca.2019.08.002⟩
European Journal of Cancer, Elsevier, 2019, 120, pp.40-46. ⟨10.1016/j.ejca.2019.08.002⟩
European Journal of Cancer, 2019, 120, pp.40-46. ⟨10.1016/j.ejca.2019.08.002⟩
European Journal of Cancer, Elsevier, 2019, 120, pp.40-46. ⟨10.1016/j.ejca.2019.08.002⟩
Background Determining the optimal biological dose (OBD) has been described as an alternative strategy to the maximum tolerated doses (MTDs) for identifying the recommended phase II trial doses (RP2Ds) of phase I anti-cancer therapies. However, the c
Autor:
Cécile Leyronnas, Jérôme Long, Pierre Heudel, Benoit You, Olivier Tredan, Romain Varnier, Sylvie Chabaud, Olivier Collard, Alain Viari, Sandrine Paindavoine, Gilles Freyer, David Pérol, Emilie Sohier, Daniel Pissaloux, Isabelle Ray-Coquard, Jean-Philippe Jacquin, Olfa Derbel, Olivia Le Saux, Valéry Attignon, Qing Wang, Nathalie Bonnin, Christian Baudet, Gwenaelle Garin, Philippe A. Cassier, Jean-Yves Blay
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2019, 118, pp.156-165. ⟨10.1016/j.ejca.2019.06.017⟩
European Journal of Cancer, Elsevier, 2019, 118, pp.156-165. ⟨10.1016/j.ejca.2019.06.017⟩
European Journal of Cancer, 2019, 118, pp.156-165. ⟨10.1016/j.ejca.2019.06.017⟩
European Journal of Cancer, Elsevier, 2019, 118, pp.156-165. ⟨10.1016/j.ejca.2019.06.017⟩
Objectives The objectives of this study were to identify actionable genomic alterations in the gynaecological subpopulation of the ProfiLER programme and to report clinical efficacy of recommended targeted treatment (RTT). Methods The ProfiLER progra
Publikováno v:
Oncologist
Oncologist, 2019, 24 (8), pp.1089-1094. ⟨10.1634/theoncologist.2018-0493⟩
Oncologist, 2019, 24 (8), pp.1089-1094. ⟨10.1634/theoncologist.2018-0493⟩
Background The objective of this study was to describe the implementation of comprehensive geriatric assessment (CGA) in clinical trials dedicated to older patients before and after the creation of the International Society of Geriatric Oncology in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc43996ff0aab2c2c7a679260bfc047d
https://hal.archives-ouvertes.fr/hal-02195231
https://hal.archives-ouvertes.fr/hal-02195231
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2017, 28 (10), pp.2606-2611. ⟨10.1093/annonc/mdx354⟩
Annals of Oncology, 2017, 28 (10), pp.2606-2611. ⟨10.1093/annonc/mdx354⟩
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (10), pp.2606-2611. ⟨10.1093/annonc/mdx354⟩
Annals of Oncology, Elsevier, 2017, 28 (10), pp.2606-2611. ⟨10.1093/annonc/mdx354⟩
Annals of Oncology, 2017, 28 (10), pp.2606-2611. ⟨10.1093/annonc/mdx354⟩
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (10), pp.2606-2611. ⟨10.1093/annonc/mdx354⟩
Background Physicians need well-addressed clinical trials assessing benefits and harm of treatments to avoid under-treatment or over-treatment of elderly patients. The main objectives of this report were to present an overview of end points used in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e415ae993a2e5fe0a1cbc67f2e9d245e
https://hal.archives-ouvertes.fr/hal-01827452
https://hal.archives-ouvertes.fr/hal-01827452